US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vivos Inc.

0.0950

+0.012615.25%

Volume:1.57M

Turnover:132.90K

Market Cap:43.11M

PE:-26.91

High:0.0950

Open:0.0811

Low:0.0779

Close:0.0824

52wk High:0.1840

52wk Low:0.0425

Shares:453.80M

Float Shares:434.00M

Volume Ratio:0.27

T/O Rate:0.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0035

EPS(LYR):-0.0043

ROE:-155.46%

ROA:-83.69%

PB:-6.46

PE(LYR):-22.12

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Vivos Inc. CEO and President Michael Korenko Reports Acquisition of Common Shares

Investigational Device Exemption (Ide) Application for Human Clinical Trials at Mayo Declined by FDA

THOMSON REUTERS

Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RDGL"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RDGL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","market":"US","secType":"STK","nameCN":"Vivos Inc.","latestPrice":0.095,"timestamp":1755802320000,"preClose":0.08243,"halted":0,"volume":1565777,"delay":15,"floatShares":434000000,"shares":453804006,"eps":-0.00353,"marketStatus":"Trading","change":0.01257,"latestTime":"08-21 14:52:00 EDT Delay","open":0.0811,"high":0.095,"low":0.0779,"amount":132900.28638809,"amplitude":0.207449,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.00353,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1755806400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.08243,"volumeRatio":0.266199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","floatShares":434000000,"roa":"-83.69%","roe":"-155.46%","lyrEps":-0.004295,"volumeRatio":0.266199,"shares":453804006,"dividePrice":0,"high":0.095,"amplitude":0.207449,"preClose":0.08243,"low":0.0779,"week52Low":0.0425,"pbRate":"-6.46","psRate":"833.18","week52High":0.184,"institutionHeld":0,"latestPrice":0.095,"eps":-0.00353,"divideRate":0,"volume":1565777,"delay":15,"ttmEps":-0.00353,"open":0.0811,"prevYearClose":0.1149,"prevWeekClose":0.0869,"prevMonthClose":0.1175,"prevQuarterClose":0.1122,"fiveDayClose":0.085,"twentyDayClose":0.133,"sixtyDayClose":0.1278},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RDGL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-18","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-06","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699246800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RDGL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RDGL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RDGL\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559096995","title":"Vivos Inc. CEO and President Michael Korenko Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559096995","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559096995?lang=en_us&edition=fundamental","pubTime":"2025-08-15 02:47","pubTimestamp":1755197243,"startTime":"0","endTime":"0","summary":"Michael Korenko, CEO and President of Vivos Inc., reported an acquisition of common shares of Vivos Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL7zNBC5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDGL","BK4082"],"gpt_icon":0},{"id":"2559952188","title":"Investigational Device Exemption (Ide) Application for Human Clinical Trials at Mayo Declined by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2559952188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559952188?lang=en_us&edition=fundamental","pubTime":"2025-08-14 20:30","pubTimestamp":1755174601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nTUABZ5TXM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","RDGL"],"gpt_icon":0},{"id":"2529500077","title":"Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529500077","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529500077?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:46","pubTimestamp":1745412402,"startTime":"0","endTime":"0","summary":"April 23 (Reuters) - Vivos Inc ::*VIVOS INC. ACHIEVES RECORD GROWTH IN ISOPET® ANIMAL CANCER TREATMENTS IN Q1 2025  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 23-APR-202512:30:00.133 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nRSD3Nvn1p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","RDGL"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RDGL\",params:#limit:6,delay:false,,,undefined,":[]}}